AzTrials
AzTrials

Body CompositionMΒT-UTHNCT05412511

Metabolic Cost of Medicine Ball Training

A study testing MB-TB and MB-NTB in people with Body Composition and Physical Fitness, run by University of Thessaly at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, the investigators will be able to estimate the metabolic cost of several foundational medicine ball training exercises. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
What is being tested?
MB-TB and MB-NTB
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteGreece
Study dates
1 May 2022to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 35 years
  • Physically active individuals
  • Free of chronic diseases
  • Free of musculoskeletal injuries
  • Nonsmokers

Who cannot join

  • Musculoskeletal injuries
  • Chronic diseases
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication before (≤6 months) and throughout the study.

Trial locations and contacts

1 site in 1 country.

Greece1 site

  • Laboratory of Exercise Physiology, Exercise Biochemistry and Sports Nutrition, School of Physical Education, Sports Sciences and Dietetics, University of Thessaly

    Trikala, 42100

Other trials in Greece

About this study

In this study, the investigators will be able to estimate the metabolic cost of several foundational medicine ball training exercises.

Read the detailed description

Medicine ball training has become a popular cardiovascular training choice in fitness centers and athletic performance enhancement facilities. Despite widespread use and growing popularity, little is known about the metabolic demands of such a training method. Therefore, the purpose of this study was to quantify the cardiovascular and metabolic cost from various foundational medicine ball exercises in order to contribute to a better planning of exercise programs in the real world.

Ten healthy young adults were assigned to execute fourteen bodyweight exercises (acute bout) of which seven exercises will be executed by throwing the medicine ball and seven exercises will be executed without a medicine ball throw. Anthropometric, metabolic, functional capacity and performance measurements were conducted at baseline. The metabolic cost was estimated from heart rate, blood lactate, resting oxygen uptake, exercise oxygen uptake, and excess post-exercise oxygen consumption measurements using a portable gas analyzer.

Being tested
MB-TB, MB-NTB
Keywords
functional fitness training, Medicine ball Training, Energy Expenditure, Oxygen Consumption, Resistance Trianing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MB-TBBehavioural

    Training exercises with throwing a medicine ball will be performed for 30 seconds and the training volume will be consisted of 1 repetition.

  • MB-NTBBehavioural

    Training exercises without throwing a medicine ball will be performed for 30 seconds and the training volume will be consisted of 1 repetition.

Study groups in NCT05412511
Study groupRoleWhat they receive
TrainingExperimentalParticipants in this arm will perform seven medicine ball training exercises (acute bout per exercise) at two different conditions [Throwing a ball (TB) and no Throwing a ball (NTB)].
Receives: Behavioral: MB-TB; Behavioral: MB-NTB
ControlNo interventionParticipants in this arm will receive no intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in exercise-induced energy expenditure

    Exercise energy expenditure (kcal) will be measured using a portable indirect calorimetry system

    Measured: At pre-exercise, during, and 30 minutes after the exercise session (a single bout lasting 30 seconds)

  2. Change in excess post-exercise oxygen consumption (EPOC)

    EPOC (kcal) will be measured using a portable indirect calorimetry system

    Measured: At 1 hour after exercise session (single bout lasting 30 seconds)

  3. Change in blood lactate concentration (BLa)

    BLa (mmol/L) concentration will be measured in a microphotometer with commercially available kits.

    Measured: At pre-exercise and 3 minutes after exercise session (a single bout lasting 30 seconds)

  4. Change in heart rate

    Heart rate (bpm) will be measured with a wearable heart rate monitor

    Measured: At pre-exercise, during, and 30 minutes after ther exercise session (a single bout lasting 30 seconds)

  5. Change in perceived exertion

    Rating of perceived exertion (RPE) will be measured with the Borg scale (0-10)

    Measured: At pre-exercise, during, and 30 minutes after the exercise session (a single bout lasting 30 seconds)

Secondary outcomes (14)

  1. Body weight

    Body weight will be measured on a beam balance with stadiometer

    Measured: At baseline

  2. Body height

    Body height will be measured on a beam balance with stadiometer

    Measured: At baseline

  3. Body mass index (BMI)

    BMI will be calculated using the Quetelet's equation

    Measured: At baseline

  4. Waist circumference (WC)

    WC (cm) will be measured using a Gullick II tape

    Measured: At baseline

  5. Hip circumference (HC)

    HC (cm) will be measured using a Gullick II tape

    Measured: At baseline

  6. Waist-to-hip ratio (WHR

    WHR will be calculated by dividing the waist by the hip measurement

    Measured: At baseline

  7. Resting metabolic rate (RMR)

    RMR (kcal) will be measured using a portable open-circuit indirect calorimeter with a ventilated hood system

    Measured: At baseline

  8. Body fat (BF) Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

    BF (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

    Measured: At baseline

  9. Fat mass (FM)t Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

    FM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

    Measured: At baseline

  10. Fat-free mass (FFM)

    FFM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

    Measured: At baseline

  11. Maximal oxygen consumption (VO2max)

    VO2max (mL/kg/min) will be assessed by a portable open-circuit spirometry system

    Measured: At baseline

  12. Maximal strength (1RM)

    1RM (kg) will be measured bilaterally on a horizontal leg press and seated chest press machine.

    Measured: At baseline

  13. Muscular endurance

    Muscular endurance (repetitions) will be measured on a 1-min curl-up and push-up test.

    Measured: At baseline

  14. Functional capacity

    Functional capacity will be assessed using a movement-based screening tool titled Functional Movement Screening (FMS). The FMS will be consisted of 7 movement tasks that will be scored from 0 to 3 points and the sum will create score ranging from 0 to 21 points (0 = pain with pattern regardless of quality, 1 = unable to perform pattern, 2 = able to perform pattern with compensation/imperfection, 3 = able to perform pattern as directed)Functional capacity will be assessed using a movement-based screening tool titled Functional Movement Screening (FMS). The FMS will be consisted of 7 movement tasks that will be scored from 0 to 3 points and the sum will create score ranging from 0 to 21 points (0 = pain with pattern regardless of quality, 1 = unable to perform pattern, 2 = able to perform pattern with compensation/imperfection, 3 = able to perform pattern as directed)

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2022
  2. Study start1 May 2022
  3. Primary completion23 Jan 2023
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Investigator
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05412511
Sponsor's protocol ID
MΒT-UTH
Acronym
MΒT-UTH
Status last verified
May 2023
First submitted
1 Jun 2022
Last updated
11 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing MB-TB and MB-NTB in people with Body Composition and Physical Fitness, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in exercise-induced energy expenditure (time frame: At pre-exercise, during, and 30 minutes after the exercise session (a single bout lasting 30 seconds)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05412511.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2023.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in